Home » Topics » BioWorld Science, Respiratory

BioWorld Science, Respiratory
RSS

Sionna closes series B financing to support development of CFTR modulators

April 20, 2022

Bridge Biotherapeutics inlicenses Shaperon's IPF candidate BBT-209

April 19, 2022

Landos Biopharma identifies new NLR family member X1 ligands

April 14, 2022

Ube Industries and HiLung to codevelop LPA1 antagonist HL-001 for IPF

March 30, 2022

FDA approves IND application for SM-17 for asthma

March 15, 2022

Mer inhibition as a promising new therapeutic strategy against septic ALI/ARDS

March 15, 2022

Sunshine Lake Pharma researchers describe JAK inhibitors

March 8, 2022

Bridge signs option agreement for CellionBioMed's ion channel modulator for IPF

March 8, 2022

LABP-73 demonstrates efficacy in preclinical models of chronic asthma

March 8, 2022

HuR ablation ameliorates allergen-induced asthmatic symptoms

March 2, 2022

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...